Passage Bio Inc (PASG) Stock Forecast & Price Target
Passage Bio Inc · NASDAQ
$4.31-0.19 (-4.22%)
15-min delayed · Aug 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Passage Bio Inc, 2 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $7.00 to $23.00 (about 3.3x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $13.25 sits 207% above the current $4.31. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-2.83 next quarter toward $-10.39 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy240%
Hold360%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Passage Bio Inc.
As of Aug, 2 of 5 firms rate PASG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PASG EPS & revenue forecast
EPS · NEXT QUARTER
$-2.83
Range $-4.06 – $-1.61 · 2 analysts · -31% YoY
Next period, 2 analysts expect Passage Bio Inc to earn $-2.83 a share (range $-4.06 – $-1.61), versus $-4.09 a year earlier. Full-year consensus is $-11.34, growing to $-10.39 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Passage Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PASG.
#1
Geulah Livshits
Chardan Capital · Rank #92
Buy
$21.00+387.2% to target
Overall win rate
45%
+ Follow
#2
Debjit Chattopadhyay
Guggenheim · Rank #111
Buy
$10.00+132.0% to target
Overall win rate
44%
+ Follow
#3
WI
Whitney Ijem
Canaccord Genuity · Rank #341
Buy
$23.00+433.6% to target
Overall win rate
32%
+ Follow
#4
Jay Olson
Oppenheimer · Rank #354
Buy
$15.00+248.0% to target
Overall win rate
33%
+ Follow
#5
YZ
Yun Zhong
Wedbush
Hold
$8.00+85.6% to target
Coverage
—
+ Follow
PASG stock forecast FAQ
What is PASG's average 12-month price target?+
The 4 analysts with a live target average $13.25 for Passage Bio Inc over the next 12 months, ranging from a $23.00 high to a $7.00 low.
Is PASG stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 2 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PASG?+
The Street-high target is $23.00 (Canaccord Genuity), and the Street-low is $7.00 (Chardan Capital). The average of all 4 active targets is $13.25.
How many Wall Street analysts cover PASG?+
5 analysts have an active rating on Passage Bio Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering PASG?+
Among analysts who currently cover PASG, Geulah Livshits of Chardan Capital has the strongest overall Quantellect track record (Rank #92). Their current call is Buy with a $21.00 target.
What is Passage Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-2.83 per share (range $-4.06 – $-1.61) across 2 analysts. Full-year EPS is projected at $-11.34, rising to $-10.39 the following year.
How much revenue is Passage Bio Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading PASG lately?+
As of Aug, 2 of 5 firms rate PASG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PASG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
